FRMD3 and Nephropathy: This effect was less pronounced for APOL1. Importantly, there was no evidence of association of FRMD3 or any of the other top 100 SNPs with T2DM-ESRD in the original GWAS, prior to accounting for these c22 nephropathy risk variants [15].